Contact
searchSearch
HMP Global
Login

Anxiety Disorders Topic Center

Conference attendees look at a poster
Conference Coverage
Digital Therapeutic Rejoyn May Aid Anxiety in MDD Patients
09/25/2025
Brionna Mendoza
The digital therapeutic Rejoyn (CT-152) outperformed a sham smartphone app in reduction of anxiety levels in adult patients with major depressive disorder (MDD).
The digital therapeutic Rejoyn (CT-152) outperformed a sham smartphone app in reduction of anxiety levels in adult patients with major depressive disorder (MDD).
The digital therapeutic Rejoyn...
09/25/2025
Psych Congress Network
open and spilled bottle of pills
News
Beta-Blockers Ineffective for Treating Psychological Symptoms of Anxiety
04/24/2025
Maria Mantas
A systematic review found no evidence of a beneficial effect from beta-blockers in treating anxiety symptoms in patients with social phobia or panic disorder with or without agoraphobia compared to either placebo or benzodiazepines.
A systematic review found no evidence of a beneficial effect from beta-blockers in treating anxiety symptoms in patients with social phobia or panic disorder with or without agoraphobia compared to either placebo or benzodiazepines.
A systematic review found no...
04/24/2025
Psych Congress Network
(Left to right) Moushumi Mukerji, MSN, PMHNP-BC, CNM and Vanessa Joy Walker, CPC, MPH Candidate.
Clinical Pearls
Clarifying Common Misconceptions About Treating Anxiety in Women
03/30/2025
Moushumi Mukerji, MSN, PMHNP-BC; Vanessa Joy Walker, CPC, MPH
Anxiety in women is often misunderstood—even in psychiatric clinical settings. Ahead of the 2025 Psych Congress NP Institute, Psych Congress Network connected with Moushumi Mukerji, MSN, PMHNP-BC, CNM, to discuss some of the key clinical...
Anxiety in women is often misunderstood—even in psychiatric clinical settings. Ahead of the 2025 Psych Congress NP Institute, Psych Congress Network connected with Moushumi Mukerji, MSN, PMHNP-BC, CNM, to discuss some of the key clinical...
Anxiety in women is often...
03/30/2025
Psych Congress NP Institute
From Psych Congress NP Institute
(Left to right) Moushumi Mukerji, MSN, PMHNP-BC, CNM and Vanessa Joy Walker, CPC, MPH Candidate.
Clinical Pearls
Adopting a Life-Stage Lens for Anxiety Treatment in Women
03/29/2025
Moushumi Mukerji, MSN, PMHNP-BC; Vanessa Joy Walker, CPC, MPH
Moushumi Mukerji, MSN, PMHNP-BC, CNM, and Vanessa Joy Walker, CPC, MPH Candidate discuss some of the key clinical takeaways from their session on treating anxiety in women patients, presented at the 2025 Psych Congress NP Institute.
Moushumi Mukerji, MSN, PMHNP-BC, CNM, and Vanessa Joy Walker, CPC, MPH Candidate discuss some of the key clinical takeaways from their session on treating anxiety in women patients, presented at the 2025 Psych Congress NP Institute.
Moushumi Mukerji, MSN, PMHNP-BC,...
03/29/2025
Psych Congress NP Institute
From Psych Congress NP Institute
How many people with anxiety disorders receive treatment?
Quiz
How many people with anxiety disorders receive treatment?
01/28/2025
Test your statistical knowledge!
Test your statistical knowledge!
Test your statistical knowledge!
01/28/2025
Psych Congress Network
How long does worry need to be present in order to diagnose GAD?
Quiz
How long does worry need to be present in order to diagnose GAD?
01/03/2025
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
01/03/2025
Psych Congress Network
A woman sits on the floor looking sad and worried.
News
FDA OKs Digital Therapeutic for Generalized Anxiety Disorder
09/13/2024
Brionna Mendoza
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug...
09/13/2024
Psych Congress Network
An older woman sits alone
News
New-Onset Anxiety Increases PD Risk in Adults 50 and Older
08/27/2024
Jolynn Tumolo
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson...
08/27/2024
Neurology
From Neurology
postpartum depression
Digital Health Interventions Show Promise in Alleviating Postpartum Depression and Anxiety
01/05/2024
Meagan Thistle
Digital health interventions modestly but notably reduce postpartum depression and anxiety symptoms compared to ‘treatment as usual,’ a systematic review found.
Digital health interventions modestly but notably reduce postpartum depression and anxiety symptoms compared to ‘treatment as usual,’ a systematic review found.
Digital health interventions...
01/05/2024
Psych Congress Network
Neuroactive Nasal Spray Promising Treatment for SAD
News
Neuroactive Nasal Spray Promising Treatment for SAD
12/07/2023
Evi Arthur
Fasedienol (PH94B), a neuroactive nasal spray, was found to be an effective treatment for social anxiety disorder (SAD) in a phase 3 trial, according to poster findings presented at the NEI Congress 2023.
Fasedienol (PH94B), a neuroactive nasal spray, was found to be an effective treatment for social anxiety disorder (SAD) in a phase 3 trial, according to poster findings presented at the NEI Congress 2023.
Fasedienol (PH94B), a...
12/07/2023
Psych Congress Network
Intranasal Fasedienol Safe, Well-Tolerated in Adults With Social Anxiety Disorder
News
Intranasal Fasedienol Safe, Well-Tolerated in Adults With Social Anxiety Disorder
11/20/2023
Jolynn Tumolo
Repeated, as-needed fasedienol was safe and well tolerated, and improved overall symptom control, in adults with social anxiety disorder (SAD), according to a poster presented at NEI Congress in Colorado Springs, Colorado, earlier this month.
Repeated, as-needed fasedienol was safe and well tolerated, and improved overall symptom control, in adults with social anxiety disorder (SAD), according to a poster presented at NEI Congress in Colorado Springs, Colorado, earlier this month.
Repeated, as-needed fasedienol...
11/20/2023
Psych Congress Network

News Articles

open and spilled bottle of pills
News
Beta-Blockers Ineffective for Treating Psychological Symptoms of Anxiety
04/24/2025
Maria Mantas
A systematic review found no evidence of a beneficial effect from beta-blockers in treating anxiety symptoms in patients with social phobia or panic disorder with or without agoraphobia compared to either placebo or benzodiazepines.
A systematic review found no evidence of a beneficial effect from beta-blockers in treating anxiety symptoms in patients with social phobia or panic disorder with or without agoraphobia compared to either placebo or benzodiazepines.
A systematic review found no...
04/24/2025
Psych Congress Network
A woman sits on the floor looking sad and worried.
News
FDA OKs Digital Therapeutic for Generalized Anxiety Disorder
09/13/2024
Brionna Mendoza
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug...
09/13/2024
Psych Congress Network
An older woman sits alone
News
New-Onset Anxiety Increases PD Risk in Adults 50 and Older
08/27/2024
Jolynn Tumolo
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson...
08/27/2024
Neurology
Neuroactive Nasal Spray Promising Treatment for SAD
News
Neuroactive Nasal Spray Promising Treatment for SAD
12/07/2023
Evi Arthur
Fasedienol (PH94B), a neuroactive nasal spray, was found to be an effective treatment for social anxiety disorder (SAD) in a phase 3 trial, according to poster findings presented at the NEI Congress 2023.
Fasedienol (PH94B), a neuroactive nasal spray, was found to be an effective treatment for social anxiety disorder (SAD) in a phase 3 trial, according to poster findings presented at the NEI Congress 2023.
Fasedienol (PH94B), a...
12/07/2023
Psych Congress Network
Intranasal Fasedienol Safe, Well-Tolerated in Adults With Social Anxiety Disorder
News
Intranasal Fasedienol Safe, Well-Tolerated in Adults With Social Anxiety Disorder
11/20/2023
Jolynn Tumolo
Repeated, as-needed fasedienol was safe and well tolerated, and improved overall symptom control, in adults with social anxiety disorder (SAD), according to a poster presented at NEI Congress in Colorado Springs, Colorado, earlier this month.
Repeated, as-needed fasedienol was safe and well tolerated, and improved overall symptom control, in adults with social anxiety disorder (SAD), according to a poster presented at NEI Congress in Colorado Springs, Colorado, earlier this month.
Repeated, as-needed fasedienol...
11/20/2023
Psych Congress Network
FDA headquarters
News
FDA Issues Warning Highlighting Risks of Ketamine for Psychiatric Disorder Treatment
10/27/2023
Meagan Thistle
The FDA has recently addressed the growing interest in compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders and warns clinicians considering their use.
The FDA has recently addressed the growing interest in compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders and warns clinicians considering their use.
The FDA has recently addressed...
10/27/2023
Psych Congress Network
Image of man with neurological issue
News
Anxiety Alters Neural Pathways for Emotional Control, Highlighting Compensatory Mechanisms
08/29/2023
Anxious individuals rely less on the dorsolateral prefrontal cortex (FPl) for controlling emotional actions, according to a recent study published in Nature Communications.
Anxious individuals rely less on the dorsolateral prefrontal cortex (FPl) for controlling emotional actions, according to a recent study published in Nature Communications.
Anxious individuals rely less on...
08/29/2023
Psych Congress Network
: Anxiety, Depression Tied to Housing Insecurity in Childhood, Adulthood
News
Anxiety, Depression Tied to Housing Insecurity in Childhood, Adulthood
06/28/2023
Evi Arthur
Housing insecurity was linked with anxiety and depression occurrence in childhood and depression occurrence in adulthood. Results from the prospective cohort study were published in JAMA Pediatrics. 
Housing insecurity was linked with anxiety and depression occurrence in childhood and depression occurrence in adulthood. Results from the prospective cohort study were published in JAMA Pediatrics. 
Housing insecurity was linked...
06/28/2023
Psych Congress Network
older man and doctor
News
Biological Aging May Be a Risk Factor for Depression, Anxiety
05/11/2023
Evi Arthur
Biological aging, as opposed to chronological, may be a risk factor for incident depression/anxiety in midlife and for older adults, according to recent study results published in the journal Nature Communications.
Biological aging, as opposed to chronological, may be a risk factor for incident depression/anxiety in midlife and for older adults, according to recent study results published in the journal Nature Communications.
Biological aging, as opposed to...
05/11/2023
Psych Congress Network
News
Anxiety Blood Test Examining Biomarkers May Help Optimize Individual Treatment
03/28/2023
Brionna Mendoza
A blood test for anxiety examining specific biomarkers to determine individual anxiety development risk, severity, and optimized therapy options has been developed.
A blood test for anxiety examining specific biomarkers to determine individual anxiety development risk, severity, and optimized therapy options has been developed.
A blood test for anxiety...
03/28/2023
Psych Congress Network
stethoscope, pills, and a brain
News
Stimulant Treatment for ADHD Associated With Psychosis and BD
09/25/2025
Maria Mantas
Stimulant use for the treatment of attention-deficit/hyperactivity disorder (ADHD) was associated with higher occurrence of psychotic symptoms, psychotic disorders, and bipolar disorder (BD), according to a systematic review.
Stimulant use for the treatment of attention-deficit/hyperactivity disorder (ADHD) was associated with higher occurrence of psychotic symptoms, psychotic disorders, and bipolar disorder (BD), according to a systematic review.
Stimulant use for the treatment...
09/25/2025
Psych Congress Network
Katherine Warburton, Stephen Stahl, and Roberto Carrara
News
Breaking the Cycle of Criminalization: Keynote Address Tackles Neuroethics, Justice Reform, and Patient Autonomy at Psych Congress 2025
09/19/2025
Maria Mantas
Discussions of ethical intervention, patient autonomy, and justice reform took center stage during the keynote address at the 2025 Psych Congress on Wednesday evening.
Discussions of ethical intervention, patient autonomy, and justice reform took center stage during the keynote address at the 2025 Psych Congress on Wednesday evening.
Discussions of ethical...
09/19/2025
Psych Congress Network
DNA strand
News
Pharmacogenomic Test Improves MDD Response and Remission Outcomes
09/15/2025
Jolynn Tumolo
Clinician use of a specific weighted multigene pharmacogenomic (PGx) test significantly improved outcomes in adult patients with major depressive disorder (MDD) with at least 1 treatment failure, according to meta-analysis results.
Clinician use of a specific weighted multigene pharmacogenomic (PGx) test significantly improved outcomes in adult patients with major depressive disorder (MDD) with at least 1 treatment failure, according to meta-analysis results.
Clinician use of a specific...
09/15/2025
Psych Congress Network
fda building sign
News
FDA Approves TMS Device for Major Depressive Disorder in Adolescents
09/11/2025
Brionna Mendoza
The US Food and Drug Administration (FDA) approved on Wednesday the Apollo Transcranial Magnetic Stimulation (TMS) Therapy devices for the adjunctive treatment of major depressive disorder (MDD) in adolescents.
The US Food and Drug Administration (FDA) approved on Wednesday the Apollo Transcranial Magnetic Stimulation (TMS) Therapy devices for the adjunctive treatment of major depressive disorder (MDD) in adolescents.
The US Food and Drug...
09/11/2025
Psych Congress Network
cannabis plant and CBD oil
News
High Levels of THC in Cannabis Products Associated With Mental Health Risks
09/11/2025
Maria Mantas
Cannabis products that contained high concentrations of delta-9-tetrahydrocannabinol (THC) were associated with psychosis, schizophrenia, and cannabis use disorder (CUD), according to a systematic review.
Cannabis products that contained high concentrations of delta-9-tetrahydrocannabinol (THC) were associated with psychosis, schizophrenia, and cannabis use disorder (CUD), according to a systematic review.
Cannabis products that contained...
09/11/2025
Psych Congress Network
child embraces mother
News
Child Depression During COVID-19 Pandemic Associated With Subsequent Maternal Depression
09/02/2025
Maria Mantas
Child depression at ages 10 and 11 years during the COVID-19 pandemic was significantly associated with later maternal depression, according to longitudinal study results.
Child depression at ages 10 and 11 years during the COVID-19 pandemic was significantly associated with later maternal depression, according to longitudinal study results.
Child depression at ages 10 and...
09/02/2025
Psych Congress Network
An orange prescription container with generic pills spilling out in front of it
News
Early ADHD Drug Treatment Linked With Reduced Risk of Suicide, Substance Misuse, and Other Adverse Outcomes
08/27/2025
Jolynn Tumolo
Patients with attention-deficit/hyperactivity disorder (ADHD) who began drug treatment within 3 months of diagnosis had significantly reduced rates of suicidal behaviors, substance misuse, traffic accidents, and criminality.
Patients with attention-deficit/hyperactivity disorder (ADHD) who began drug treatment within 3 months of diagnosis had significantly reduced rates of suicidal behaviors, substance misuse, traffic accidents, and criminality.
Patients with...
08/27/2025
Psych Congress Network
An illustrated picture shows two cartoon doctors, one holding up a magnifying glass to a cartoon brain.
News
Investigational App for Negative Schizophrenia Symptoms Meets Primary Trial Endpoint
08/25/2025
Jolynn Tumolo
An investigational prescription digital therapeutic targeting negative symptoms in patients with schizophrenia met its primary endpoint in a pivotal phase 3 randomized controlled study.
An investigational prescription digital therapeutic targeting negative symptoms in patients with schizophrenia met its primary endpoint in a pivotal phase 3 randomized controlled study.
An investigational prescription...
08/25/2025
Psych Congress Network
tired man rubs eyes
News
Vulnerability to Inflammation-Related Depression Exaggerated in Older Adults With Insomnia
08/18/2025
Jolynn Tumolo
Compared with older adults without insomnia, older adults with the sleep disorder experienced a 3-fold greater increase in depressed mood and depressive symptoms after exposure to an inflammatory challenge, according to study findings.
Compared with older adults without insomnia, older adults with the sleep disorder experienced a 3-fold greater increase in depressed mood and depressive symptoms after exposure to an inflammatory challenge, according to study findings.
Compared with older adults...
08/18/2025
Psych Congress Network
A woman lies in bed awake due to insomnia
News
Cannabinoids Produce Worse Sleep Outcomes in Small Pilot Study
08/15/2025
Brionna Mendoza
A single dose of tetrahydrocannabinol/cannabidiol (THC/CBD) resulted in worse sleep for study participants with insomnia.
A single dose of tetrahydrocannabinol/cannabidiol (THC/CBD) resulted in worse sleep for study participants with insomnia.
A single dose of...
08/15/2025
Neurology

Interactive Features

How many people with anxiety disorders receive treatment?
Quiz
How many people with anxiety disorders receive treatment?
01/28/2025
Test your statistical knowledge!
Test your statistical knowledge!
Test your statistical knowledge!
01/28/2025
Psych Congress Network
How long does worry need to be present in order to diagnose GAD?
Quiz
How long does worry need to be present in order to diagnose GAD?
01/03/2025
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
01/03/2025
Psych Congress Network
How many weeks must separation anxiety symptoms be present to diagnose children?
Quiz
How many weeks must separation anxiety symptoms be present to diagnose children?
11/10/2023
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
11/10/2023
Psych Congress Network
quiz
Quiz
Which symptoms indicate a panic disorder diagnosis?
03/30/2023
Do you know which diagnostic criteria symptoms must be present to make a panic disorder diagnosis? Take the quiz to find out!
Do you know which diagnostic criteria symptoms must be present to make a panic disorder diagnosis? Take the quiz to find out!
Do you know which diagnostic...
03/30/2023
Psych Congress Network
By how much did deep brain stimulation reduce OCD symptoms?
Quiz
By how much did deep brain stimulation reduce OCD symptoms?
12/12/2022
Test your knowledge with a quick quiz!
Test your knowledge with a quick quiz!
Test your knowledge with a quick...
12/12/2022
Psych Congress Network
Quiz
Quiz
What percent of adults report anxiety relating to their mental health?
01/28/2022
According to a recent APA poll, what percent of adults say that they have anxiety relating to their mental health?
According to a recent APA poll, what percent of adults say that they have anxiety relating to their mental health?
According to a recent APA poll,...
01/28/2022
Psych Congress Network
a cloud with three z's
Quiz
Test Your Knowledge – ADHD and Sleep: Why Non-Stimulants Might Be the Right Choice (Part 1)
09/19/2025
Can you optimize ADHD control and protect sleep? Take this quick quiz on viloxazine ER’s role in patients with nighttime challenges.
Can you optimize ADHD control and protect sleep? Take this quick quiz on viloxazine ER’s role in patients with nighttime challenges.
Can you optimize ADHD control...
09/19/2025
Psych Congress Network
Dr Greg Mattingly
Quiz
Test Your Knowledge – Viloxazine ER: A New Era in ADHD Treatment?
09/17/2025
How well do you know the clinical impact and unique mechanism of viloxazine ER? Take this short quiz to find out.
How well do you know the clinical impact and unique mechanism of viloxazine ER? Take this short quiz to find out.
How well do you know the...
09/17/2025
Psych Congress Network
Craig Chepke, MD, DFAPA
Quiz
Muscarinic Receptor-Based Options for Treatment-Resistant Schizophrenia
09/12/2025
Craig Chepke, MD, DFAPA
Do you remember the details of this interview with Dr Chepke?
Do you remember the details of this interview with Dr Chepke?
Do you remember the details of...
09/12/2025
Psych Congress Network
medication
Quiz
Test Your Knowledge: Study Results Link Non-Stimulant ADHD Therapy and Prescription Stimulant Misuse in Adolescents
09/09/2025
What does research reveal about the risk of non-stimulants? Test your understanding of ADHD treatment and stimulant misuse.
What does research reveal about the risk of non-stimulants? Test your understanding of ADHD treatment and stimulant misuse.
What does research reveal about...
09/09/2025
Psych Congress Network
Dr Rakesh Jain
Quiz
Test Your Knowledge – Targeting Hyperactivity and Impulsivity in Adolescents: A Look at Viloxazine ER
09/04/2025
Think you understand the role of non-stimulants in ADHD treatment? Take this quick quiz to test your knowledge of viloxazine ER.
Think you understand the role of non-stimulants in ADHD treatment? Take this quick quiz to test your knowledge of viloxazine ER.
Think you understand the role of...
09/04/2025
Psych Congress Network
Dr Rakesh Jain
Quiz
Test Your Knowledge: Dr Rakesh Jain on Nonstimulant Treatment Options for Pediatric ADHD
09/03/2025
How well do you know the evolving landscape of non-stimulant ADHD treatments? Take this quick quiz to find out.
How well do you know the evolving landscape of non-stimulant ADHD treatments? Take this quick quiz to find out.
How well do you know the...
09/03/2025
Psych Congress Network
Wooden blocks spelling QUIZ
Quiz
Test Your Knowledge: Viloxazine ER Added to Stimulant Treatment for Pediatric ADHD Appears Safe, Effective
09/02/2025
Can viloxazine ER enhance stimulant therapy in pediatric ADHD? Take this quick quiz to test your knowledge.
Can viloxazine ER enhance stimulant therapy in pediatric ADHD? Take this quick quiz to test your knowledge.
Can viloxazine ER enhance...
09/02/2025
Psych Congress Network
Drs Mattingly, Price, Amann Part 3
Quiz
Test Your Knowledge – Navigating ADHD Care Forward: The Future of ADHD
08/27/2025
Take this quick quiz to test your knowledge on combination treatment strategies, novel mechanisms, and how emerging data is reshaping care for complex patients of all ages.
Take this quick quiz to test your knowledge on combination treatment strategies, novel mechanisms, and how emerging data is reshaping care for complex patients of all ages.
Take this quick quiz to test...
08/27/2025
Psych Congress Network
Drs Mattingly, Price, Amann Part 2
Quiz
Test Your Knowledge – Real-World Data Deep Dive: Viloxazine ER Compared With Atomoxetine for ADHD Study
08/25/2025
Discover how viloxazine ER compares to atomoxetine in real-world ADHD treatment—test your knowledge with this short, expert-driven quiz.
Discover how viloxazine ER compares to atomoxetine in real-world ADHD treatment—test your knowledge with this short, expert-driven quiz.
Discover how viloxazine ER...
08/25/2025
Psych Congress Network
blocks spelling out the word "quiz"
Quiz
Initiating Clozapine in Patients With Schizophrenia
08/15/2025
In which of the following scenarios does the American Psychiatric Association (APA) recommend initiating clozapine in patients with schizophrenia?
In which of the following scenarios does the American Psychiatric Association (APA) recommend initiating clozapine in patients with schizophrenia?
In which of the following...
08/15/2025
Psych Congress Network

Blogs
Blog
Reducing the Burden of Generalized Anxiety Disorder
04/14/2021
Urgent action is needed from mental health providers to reduce the public health burden of anxiety disorders, which are widely prevalent yet often go undiagnosed, Anxiety Disorders Section Editor Manish K. Jha, MBBS, says.
Urgent action is needed from mental health providers to reduce the public health burden of anxiety disorders, which are widely prevalent yet often go undiagnosed, Anxiety Disorders Section Editor Manish K. Jha, MBBS, says.
Urgent action is needed from...
04/14/2021
Psych Congress Network
Blog
Are Benzodiazepines the Next Opioid Crisis?
02/19/2019
Andrew Penn, RN, MS, NP, CNS, APRN-BC
BLOG: A study recently published in JAMA found that as our profession has been working tirelessly to curtail prescriptions for opioids we are prescribing more and more benzodiazepines.
BLOG: A study recently published in JAMA found that as our profession has been working tirelessly to curtail prescriptions for opioids we are prescribing more and more benzodiazepines.
BLOG: A study recently published...
02/19/2019
Psych Congress Network
Blog
Psilocybin Studies: A New Ray of Hope for Psychiatry?
12/01/2016
Andrew Penn, RN, MS, NP, CNS, APRN-BC
BLOG: These studies were the latest findings showing that psychedelics, erroneously dismissed as mere intoxicants and swept up in the hysteria of the Nixon-era drug wars, could prove to be as important to psychiatry as penicillin was to...
BLOG: These studies were the latest findings showing that psychedelics, erroneously dismissed as mere intoxicants and swept up in the hysteria of the Nixon-era drug wars, could prove to be as important to psychiatry as penicillin was to...
BLOG: These studies were the...
12/01/2016
Psych Congress Network
Blog
Psychedelics: What to Tell Patients Today
08/25/2015
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Psychedelic compounds are powerful, and they have great potential to help patients with intractable conditions. Yet any compound with that kind of power also has the potential to harm, and that harm should not be trivialized.
Psychedelic compounds are powerful, and they have great potential to help patients with intractable conditions. Yet any compound with that kind of power also has the potential to harm, and that harm should not be trivialized.
Psychedelic compounds are...
08/25/2015
Psych Congress Network
marc agronin md
Faculty Insights
Alzheimer Disease Prevention: Part 2
07/29/2024
Marc E. Agronin, MD
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated...
07/29/2024
Psych Congress Network
Rakesh Amin, MD.
Blog
Treating Schizophrenia: The Importance of Early Identification and Intervention
06/13/2023
Rakesh Amin, MD
Rakesh Amin, MD, discusses the importance of partnering with patients and caregivers to set treatment goals and the importance of introducing long-acting injectables earlier in the treatment of schizophrenia.
Rakesh Amin, MD, discusses the importance of partnering with patients and caregivers to set treatment goals and the importance of introducing long-acting injectables earlier in the treatment of schizophrenia.
Rakesh Amin, MD, discusses the...
06/13/2023
Psych Congress Network
Marc Agronin, MD.
Blog
Alzheimer Disease Prevention
08/30/2022
Marc E. Agronin, MD
Psych Congress Network Section Editor Mark Agronin, MD, provides expert clinical insights on reducing the risk for Alzheimer disease and delaying its onset and progression.
Psych Congress Network Section Editor Mark Agronin, MD, provides expert clinical insights on reducing the risk for Alzheimer disease and delaying its onset and progression.
Psych Congress Network Section...
08/30/2022
Psych Congress Network
Ed Jones, PhD
Blog
How Our Clinicians Can Help Fix the US Health Care System
07/28/2022
Ed Jones, PhD
Ed Jones, PhD, discusses the need for a clinical refocusing that includes broad access to psychosocial solutions and ensuring socially informed clinicians can help underserved communities.
Ed Jones, PhD, discusses the need for a clinical refocusing that includes broad access to psychosocial solutions and ensuring socially informed clinicians can help underserved communities.
Ed Jones, PhD, discusses the...
07/28/2022
Psych Congress Network
Ed Jones, PhD
Perspective
The Universal Behavior Model: A Comprehensive Approach to Integrated Care
07/21/2022
Ed Jones, PhD
Ed Jones, PhD: "We miss this psychosocial aspect of care today...What is missing?  We need psychotherapists based in primary care, often focused on mundane issues rather than the complexities of diagnosis or treatment."
Ed Jones, PhD: "We miss this psychosocial aspect of care today...What is missing?  We need psychotherapists based in primary care, often focused on mundane issues rather than the complexities of diagnosis or treatment."
Ed Jones, PhD: "We miss this...
07/21/2022
Psych Congress Network
Chan_Khan_Digital Mental Health
Blog
Who will use it? How to Get Digital Mental Health Apps Into the Hands of Patients
04/27/2022
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, discuss how to encourage patients to use digital mental health apps.
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, discuss how to encourage patients to use digital mental health apps.
Steven Chan, MD, MBA, and Burhan...
04/27/2022
Psychiatry & Behavioral Health
Chan_Khan_Digital Mental Health
Blog
How to Navigate Quality Issues With Mental Health Apps
04/21/2022
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, navigating quality issues with digital mental health applications.
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, navigating quality issues with digital mental health applications.
Steven Chan, MD, MBA, and Burhan...
04/21/2022
Psychiatry & Behavioral Health
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Blog
How New NPs Can Find Mentors
03/04/2022
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains...
03/04/2022
Psych Congress Network
Julie Bailey
Blog
How to Be a Safe Space for Someone
02/08/2022
In this blog, Julie Bailey, LCPC, shares her insights on providing a safe space for patients to discuss these social anxieties, as well as tips to share with patients about slowly reintegrating into life after COVID-19.
In this blog, Julie Bailey, LCPC, shares her insights on providing a safe space for patients to discuss these social anxieties, as well as tips to share with patients about slowly reintegrating into life after COVID-19.
In this blog, Julie Bailey,...
02/08/2022
Psych Congress Network
major depressive disorder
Blog
The Best and Worst Changes Brought On By the Pandemic
01/31/2022
Mental health advocate, Dorothy Watson shares her insights about the impact the pandemic has had on mental health and where we go from here.
Mental health advocate, Dorothy Watson shares her insights about the impact the pandemic has had on mental health and where we go from here.
Mental health advocate, Dorothy...
01/31/2022
Psych Congress Network

Posters

Adjunctive Treatment With Seltorexant Improved Patient-Reported Depressive Symptoms, Insomnia Symptoms, and Overall Health in Major Depressive Disorder With Insomnia
Background: We report secondary/exploratory endpoints assessing patient-reported depressive symptoms, insomnia symptoms, and health-related quality of life (HRQoL) from a phase 3, double-...
11/26/2024
Guiding antidepressant choice by applying deep learning approaches on individual patient-derived neurons: a window to drug efficacy in each patient
Depression treatment remains a significant clinical challenge due to the variability in patient responses to antidepressant medications. Outside of pharmacogenetic testing, established mo...
11/26/2024
Clinical effectiveness and persistence on esketamine nasal spray in patients with treatment-resistant depression overall and among transcranial magnetic stimulation-naïve subgroup
BACKGROUND: Esketamine nasal spray and transcranial magnetic stimulation (TMS) are used for treatment-resistant depression (TRD), but little is known about the sequence in which these the...
11/26/2024
Real-world clinical effectiveness of esketamine nasal spray based on the Montgomery-Asberg Depression Rating Scale (MADRS) among patients with treatment-resistant depression in the United States
BACKGROUND: Clinical trials for esketamine nasal spray in treatment resistant depression (TRD) often assess efficacy using Montgomery-Asberg Depression Rating Scale (MADRS)-based primary ...
11/26/2024
Response and remission on esketamine nasal spray in patients with treatment-resistant depression overall and among transcranial magnetic stimulation-naïve subgroup
BACKGROUND: Both esketamine nasal spray and transcranial magnetic stimulation (TMS) are indicated for treatment-resistant depression (TRD), but there are no guidelines on the sequence of...
11/26/2024
Comparison of Real-world Response and Remission among Patients with Treatment-Resistant Depression Treated with Esketamine Nasal Spray or Antipsychotic Augmentation
BACKGROUND: Esketamine nasal spray and second-generation antipsychotic augmentation (SGA) are approved therapies for treatment-resistant depression (TRD). Prospective randomized ESCAPE-TR...
11/26/2024
Effect of Centanafadine on AISRS Over 6 Weeks of Treatment in Adults with ADHD: A Pooled Analysis of Two Phase 3 Trials
TBD
11/26/2024
Impact of Centanafadine on the ASRS After 6 Weeks of Treatment of ADHD in Adults: A Pooled Analysis of Two Phase 3 Trials
Hypothesis/Objective: To evaluate the impact of centanafadine (CTN)—a norepinephrine, dopamine, serotonin reuptake inhibitor—on patient-reported assessment of the frequency of core sympto...
11/26/2024
Prescription Digital Therapeutics in Psychiatry: Virtual CME Advances Physician Knowledge and Confidence
Background: Digital therapeutic technologies (DTx) are emerging rapidly, and clinicians are challenged to understand their benefits and how they fit into practice. Physicians require educ...
11/26/2024
Assessing Participant Experience with KarXT Treatment Using In-Trial Qualitative Interviews: Perceived Effect on Symptoms During a Long-Term Phase 3 Trial in Schizophrenia
KarXT is a novel investigational muscarinic M1/M4 receptor agonist that, unlike currently available antipsychotics, does not directly block dopamine D2 receptors. A new drug application f...
11/26/2024

Practice Tools

Saundra's Corner
Hamilton Anxiety Rating Scale (HAM-A)
01/28/2019
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
...
01/28/2019
Psych Congress Network
Saundra's Corner
Social Phobia Inventory (SPIN)
09/28/2016
How to Use Valid measure of severity of social phobia symptoms Patient-rated assessment of the three clinically important symptom domains of social phobia Sensitive to the reduction in symptoms over time Brief, simple and easy to...
How to Use Valid measure of severity of social phobia symptoms Patient-rated assessment of the three clinically important symptom domains of social phobia Sensitive to the reduction in symptoms over time Brief, simple and easy to...
How to Use Valid measure of...
09/28/2016
Psych Congress Network
Saundra's Corner
Mini-Social Phobia Inventory (Mini-SPIN)
09/28/2016
How to Use Screening tool for social anxiety disorder (SAD) developed by Dr. Jonathan Davidson of Duke University Medical Center  Based on the longer 17-item social phobia inventory (SPIN)  Self-rated scale 3-items about...
How to Use Screening tool for social anxiety disorder (SAD) developed by Dr. Jonathan Davidson of Duke University Medical Center  Based on the longer 17-item social phobia inventory (SPIN)  Self-rated scale 3-items about...
How to Use Screening tool...
09/28/2016
Psych Congress Network
Saundra's Corner
Generalized Anxiety Disorder-7 (GAD-7)
09/28/2016
How to Use the GAD-7 Patients circle one of the 4 numbers (representing severity) associated with 7 problems. If patients identify any problems, they then indicate (by checking the appropriate box) the degree to which these problems made it...
How to Use the GAD-7 Patients circle one of the 4 numbers (representing severity) associated with 7 problems. If patients identify any problems, they then indicate (by checking the appropriate box) the degree to which these problems made it...
How to Use the GAD-7 Patients...
09/28/2016
Psych Congress Network
Saundra's Corner
Anxiety Disorders
09/28/2016
Generalized Anxiety Disorder-7 (GAD-7) Hamilton Anxiety Rating Scale (HAM-A) Mini-Social Phobia Inventory (Mini SPIN) Social Phobia Inventory (SPIN)
Generalized Anxiety Disorder-7 (GAD-7) Hamilton Anxiety Rating Scale (HAM-A) Mini-Social Phobia Inventory (Mini SPIN) Social Phobia Inventory (SPIN)
Generalized Anxiety...
09/28/2016
Psych Congress Network
Saundra's Corner
Medication Adherence Rating Scale (MARS)
01/29/2019
  Click here for Medication Adherence Rating Scale (MARS) - page 7      The total score ranges from 0-10 with a higher score indicating better adherence   Strengths Self-report...
  Click here for Medication Adherence Rating Scale (MARS) - page 7      The total score ranges from 0-10 with a higher score indicating better adherence   Strengths Self-report...
  Click here for...
01/29/2019
Psych Congress Network
Saundra's Corner
Sheehan Disability Scale (SDS)
01/28/2019
Click here for website for SDS How to Use The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.  How to Score Total score 0-30 (0 unimpaired, 30 highly...
Click here for website for SDS How to Use The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.  How to Score Total score 0-30 (0 unimpaired, 30 highly...
Click here for website for SDS...
01/28/2019
Psych Congress Network
Saundra's Corner
Brief Psychiatric Rating Scale (BPRS)
01/28/2019
  How to Use The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale. The BPRS is used as part of a clinical interview in which the clinician makes...
  How to Use The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale. The BPRS is used as part of a clinical interview in which the clinician makes...
...
01/28/2019
Psych Congress Network
Saundra's Corner
The Mini International Neuropsychiatric Interview
01/28/2019
How to Use The MINI is a widely used psychiatric structured diagnostic interview instrument.  To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.   The MINI...
How to Use The MINI is a widely used psychiatric structured diagnostic interview instrument.  To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.   The MINI...
How to Use The MINI is...
01/28/2019
Psych Congress Network
Saundra's Corner
MINI Screen
01/28/2019
How to Use The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.   Click here for the website for the MINI Screen     How to...
How to Use The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.   Click here for the website for the MINI Screen     How to...
How to Use The MINI Screen...
01/28/2019
Psych Congress Network
Saundra's Corner
Patient Health Questionnaire (PHQ-9)
01/28/2019
How to Use The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use The Patient Health...
01/28/2019
Psych Congress Network
Saundra's Corner
WHO (Five) Well-Being Index (WHO-5)
01/28/2019
How to Use Five items rated on 6-point Likert scale Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use Five items rated on 6-point Likert scale Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use Five items rated...
01/28/2019
Psych Congress Network
Saundra's Corner
Beck Depression Inventory-II (BDI-II)
01/28/2019
How to Use The Beck Depression Inventory-II (BDI-II): 1996 revision of the BDI 21-item self-report multiple-choice inventory ~ 10 minutes to...
How to Use The Beck Depression Inventory-II (BDI-II): 1996 revision of the BDI 21-item self-report multiple-choice inventory ~ 10 minutes to...
How to...
01/28/2019
Psych Congress Network
Saundra's Corner
Mood Disorder Questionnaire (MDQ)
01/28/2019
How to Use The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.   The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.   The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use The Mood Disorder...
01/28/2019
Psych Congress Network
Saundra's Corner
Hamilton Anxiety Rating Scale (HAM-A)
01/28/2019
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
...
01/28/2019
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Sign Up

Psych Congress Network Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use